Central serous retinopathy associated with topical oral corticosteroid use: a case report

被引:4
作者
O'Brien, Preston [1 ]
Young, Ryan C. [1 ,2 ]
Ghafoori, Shelley Day [1 ,2 ]
Harper, C. Armitage [1 ,2 ]
Wong, Robert W. [1 ,2 ]
机构
[1] Austin Retina Associates, 801 W 38th St,Suite 200, Austin, TX 78705 USA
[2] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA
关键词
Pigment epithelial detachment; Central serous chorioretinopathy; Fluocinonide; Topical oral gel; CHORIORETINOPATHY; GLUCOCORTICOIDS;
D O I
10.1186/s13256-019-2143-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use. Case presentation A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid. Conclusions To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association.
引用
收藏
页数:6
相关论文
共 31 条
[1]  
BASTI CP, 1987, J CLIN INVEST, V80, P848
[2]   Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis [J].
Baumal, CR ;
Martidis, A ;
Truong, SN .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (06) :926-928
[3]   SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY A Randomized Controlled Crossover Study [J].
Bousquet, Elodie ;
Beydoun, Talal ;
Rothschild, Pierre-Raphael ;
Bergin, Ciara ;
Zhao, Min ;
Batista, Rui ;
Brandely, Marie-Laure ;
Couraud, Benedicte ;
Farman, Nicolette ;
Gaudric, Alain ;
Chast, Francois ;
Behar-Cohen, Francine .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (12) :2505-2515
[4]   Central serous chorioretinopathy and glucocorticoids [J].
Bouzas, EA ;
Karadimas, P ;
Pournaras, CJ .
SURVEY OF OPHTHALMOLOGY, 2002, 47 (05) :431-448
[5]   Corticosteroids and central serous chorioretinopathy [J].
Carvalho-Recchia, CA ;
Yannuzzi, LA ;
Negrao, S ;
Spaide, RF ;
Freund, KB ;
Rodriguez-Coleman, H ;
Lenharo, M ;
Iida, T .
OPHTHALMOLOGY, 2002, 109 (10) :1834-1837
[6]   Localized topical steroid use and central serous retinopathy [J].
Chan, Lauren Y. ;
Adam, Robert S. ;
Adam, David N. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) :425-426
[7]   Eplerenone in the treatment of central serous chorioretinopathy: A review of the literature [J].
Chatziralli I. ;
Vlachodimitropoulou A. ;
Daoula C. ;
Vrettou C. ;
Galani E. ;
Theodossiadis G. ;
Theodossiadis P. .
International Journal of Retina and Vitreous, 4 (1)
[8]   CENTRAL SEROUS RETINOPATHY AND PREGNANCY [J].
CHUMBLEY, LC ;
FRANK, RN .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 77 (02) :158-160
[9]   EFFECTS OF VITAMIN A AND GLUCOCORTICOIDS UPON INFLAMMATION AND COLLAGEN SYNTHESIS [J].
EHRLICH, HP ;
TARVER, H ;
HUNT, TK .
ANNALS OF SURGERY, 1973, 177 (02) :222-227
[10]  
Ezra N, 2011, J DRUGS DERMATOL, V10, P918